Oryl Photonics Secures $2.5 Million in Funding Round for Revolutionary Solubility Measurement Instrument

Oryl Photonics is thrilled to announce that it has successfully raised $2,500,000 in its latest funding round, a significant milestone that will propel the company forward in revolutionizing the solubility measurement landscape. With solubility assessment often being a laborious and costly bottleneck in research and development, Oryl Photonics addresses these challenges head-on with its innovative, patented light-scattering technology. Our instrument not only simplifies the measurement process but also drastically reduces the time and money spent on repetitive workflows, enabling scientists and researchers to focus more on their core objectives. This funding will be critical in accelerating product development and further enhancing our offerings to provide quick and reproducible solubility data. The unique capability of our solution brings together the best of nephelometry and LC-MS—delivering results that are fast, economical, accurate, and highly reproducible—all while championing sustainability through the responsible use of resources. With the newly acquired funds, Oryl aims to expand its research initiatives, enhance marketing efforts, and drive customer engagement to broaden our impact across the pharmaceutical, biotechnology, and academic sectors. We are excited about the journey ahead and look forward to empowering researchers to overcome solubility challenges effectively, paving the way for accelerated innovation and sustainable practices in scientific research.